FindTrial
Sign In

This study aimed to compare photobiomodulation and the use of non-steroidal anti-inflammatory drugs after surgical removal of lower lip lesions with the high intensity diode laser.

Comparative analysis of the use of non-steroidal Photobiomodulation and Anti-inflammatory after surgical removal of Lower Lip Lesions with High Power Diode Laser

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5y4t9t
Enrollment
Unknown
Registered
2019-11-21
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatognathic diseases

Interventions

All 20 subjects will undergo surgical treatment using the Thera Laser Surgery® Diode Laser - DMC Equipment, São Carlos, Brazil) at infrared wavelength (808 ~ 830 nm ± 20 nm), power 2 W, continuously ,
Procedure/surgery
E02.594

Sponsors

Universidade Estadual da Paraíba
Lead Sponsor
Universidade Estadual da Paraíba
Collaborator

Eligibility

Age
No minimum to 0 Years

Inclusion criteria

Inclusion criteria: The study included patients who sought care and were referred to the Interdisciplinary League for Combating Oral Cancer (LINCCO) and agreed to participate. Subjects will be studied, regardless of gender and age, with clinical diagnosis of lower lip injuries. For the inclusion of individuals, lesions should present a clinical aspect of mucocele.

Exclusion criteria

Exclusion criteria: Individuals on continuous use of analgesic or anti-inflammatory medication, immunosuppressed or immunosuppressed were excluded from this study.

Design outcomes

Primary

MeasureTime frame
Expected Outcome 1: Postoperative pain is estimated to be lower in the photobiomodulation group (mean = 1.5), one, three, and seven days after intervention, measured by visual analog scale.     ;Expected Outcome 2: The degree of patient satisfaction is expected to be between optimal and excellent for both groups, measured by parameters ranging from very poor to excellent.;Expected Outcome 3: The size of the surgical wound is expected to decrease to 0 at 21 days of follow-up in the laser group, while in the anti-inflammatory group the surgical wound will still remain for 30 days after intervention.;Expected Outcome 4: The average quality of life as measured by the Oral Health Impact Profile (OHIP-14) is estimated to be between 1.5 and 2.5 for both groups.—

Secondary

MeasureTime frame
Expected Outcome 1: Surgical wounds from both groups, when resulting from larger lesions, are expected to take longer to regress in size (approximately 30 days after intervention).—

Countries

Brazil

Contacts

Public ContactPedro José Targino Ribeiro

Universidade Estadual da Paraíba

targino9@gmail.com+55 83 3315-3471

Outcome results

None listed

Source: REBEC (via WHO ICTRP)